Clinical Trial Update: A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing S1 generic with capecitabine in metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• S1 generic

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 3 | Status: TERMINATED